Jill Stefanelli
Director/Board Member en NAVIDEA BIOPHARMACEUTICALS, INC. .
Fortuna: 33 900 $ al 31/03/2024
Perfil
Jill Bieker Stefanelli is an Independent Director at Navidea Biopharmaceuticals, Inc. since 2023.
Previously, she was the President, Director & Chief Business Officer at Paige.
Ai, Inc. She obtained her undergraduate, graduate, and doctorate degrees from Kansas State University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
16/11/2023 | 941 667 ( 0.94% ) | 33 900 $ | 31/03/2024 |
Cargos activos de Jill Stefanelli
Empresas | Cargo | Inicio |
---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 01/06/2023 |
Antiguos cargos conocidos de Jill Stefanelli.
Empresas | Cargo | Fin |
---|---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | President | - |
Formación de Jill Stefanelli.
Kansas State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Jill Stefanelli